The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Multicenter retrospective analysis of systemic chemotherapy in poorly differentiated neuroendocrine carcinoma of the digestive system.
Tomohiro Yamaguchi
No relevant relationships to disclose
Nozomu Machida
No relevant relationships to disclose
Akiyoshi Kasuga
No relevant relationships to disclose
Hideaki Takahashi
No relevant relationships to disclose
Kentaro Sudo
No relevant relationships to disclose
Tomohiro Nishina
No relevant relationships to disclose
Kazutoshi Tobimatsu
No relevant relationships to disclose
Kenji Ishido
No relevant relationships to disclose
Junji Furuse
Consultant or Advisory Role - Bayer; Chugai Pharma; Eisai
Honoraria - Bayer; Lilly; Taiho Pharmaceutical
Narikazu Boku
Honoraria - Daiichi Sankyo; Ono Pharmaceutical ; Taiho Pharmaceutical; Takeda
Research Funding - Taiho Pharmaceutical